# Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients

> **NCT00600990** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 624 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting
- Nausea and Vomiting, Postoperative

## Interventions

- **DRUG:** GW597599

## Key facts

- **NCT ID:** NCT00600990
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 624 (ACTUAL)
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600990, "Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00600990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*